Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.
about
Surgery for cholangiocarcinoma: the role of liver transplantationBrazilian society of hepatology recommendations for the diagnosis and management of autoimmune diseases of the liverDiagnostic and therapeutic biomarkers in pancreaticobiliary malignancyAdvanced endoscopic imaging of indeterminate biliary stricturesHow Should Cancer Surveillance in Primary Sclerosing Cholangitis Be Performed?Risk stratification in autoimmune cholestatic liver diseases: Opportunities for clinicians and trialistsCholangiocarcinoma and malignant bile duct obstruction: A review of last decades advances in therapeutic endoscopyPrimary sclerosing cholangitis: diagnosis and treatmentCancer review: CholangiocarcinomaBiliary strictures: diagnostic considerations and approach.Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinomaCholangiocarcinoma: Current Knowledge and New DevelopmentsLong-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitisClassification, diagnosis, and management of cholangiocarcinomaInflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features.Diagnosis of cholangiocarcinoma.miR-34a-dependent overexpression of Per1 decreases cholangiocarcinoma growth.Chronic inflammation and cytokines in the tumor microenvironment.MiR-204 down-regulation elicited perturbation of a gene target signature common to human cholangiocarcinoma and gastric cancerABCB4 missense mutations D243A, K435T, G535D, I490T, R545C, and S978P significantly impair the lipid floppase and likely predispose to secondary pathologies in the human population.Results of a phase I-II study on intraductal confocal microscopy (IDCM) in patients with common bile duct (CBD) stenosis.Methylated Bone Morphogenetic Protein 3 (BMP3) Gene: Evaluation of Tumor Suppressor Function and Biomarker Potential in Biliary Cancer.Hepatobiliary complications of inflammatory bowel disease.Risk factors for gallbladder cancer and cholangiocarcinoma: similarities, differences and updates.Cholangiocarcinoma: new insights into disease pathogenesis and biology.Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis.New insights on cholangiocarcinoma.Comparative proteomic profiling of human bile reveals SSP411 as a novel biomarker of cholangiocarcinoma.Risk factors for hilar cholangiocarcinoma: a case-control study in China.Intraductal papillary neoplasm of the bile duct developing in a patient with primary sclerosing cholangitis: a case reportEpidemiology of primary and secondary liver cancers.Diagnostic approach using endosonography guided fine needle aspiration for lymphadenopathy in primary sclerosing cholangitis.ERCP with probe-based confocal laser endomicroscopy for the evaluation of dominant biliary stenoses in primary sclerosing cholangitis patients.Clinical diagnosis and staging of cholangiocarcinomaHilar cholangiocarcinoma: diagnosis, treatment options, and management.Suppression of thymosin β10 increases cell migration and metastasis of cholangiocarcinoma.Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine?Risk factors for cholangiocarcinomaPer-oral cholangioscopy.Current trends in living donor liver transplantation for primary sclerosing cholangitis.
P2860
Q24647147-703EFBC3-AE47-4608-907F-5DEE9C1A84D5Q26766699-1EDFE3E6-DA9F-4522-BBDC-EB1FA1372F2AQ26767120-9C045491-F8B1-4963-95C6-2EABF22F3D92Q26775370-9AE5A7A1-6235-49DF-9286-BB065E03F35CQ26782878-72D89692-CF69-4B1C-83BF-7416EBFDD6A2Q26796355-561C0ED6-2CD0-4646-BE92-A44569DE2B4AQ26823868-950CF6B1-A4E8-482E-BCC2-1A61B1B88397Q26829216-7469507C-DA87-4BBA-9CDF-E0C049D39097Q26865200-58E7F229-94ED-4D1C-B91C-0D77259385DAQ26998582-2BF06EC6-45D0-4276-B5A3-2F91C38606D8Q27852856-EE571B28-0B20-4F65-AF5F-A4A2C6E5FFDBQ28076098-B6FB4A6E-5C4D-45A2-8A3D-9090FF2676ECQ28263151-7E78D3C5-A998-4062-8259-3B1951844524Q28275153-F4718613-0FCB-479D-BB90-8DDAB43ED983Q30234950-8BE0D6E8-2F58-4E0B-AB6C-ACF568E02AC0Q30493559-146922A7-8C0D-4BD2-98D7-63329B170AB0Q30760000-E809EE6F-0766-4FB9-B237-BC37BAC00723Q33678275-91D24CAF-6826-4E84-8505-93C69FD7C48DQ33728068-18C6238F-11D3-4CE1-9237-3C70CF2E9FBEQ33844494-4784AA00-BAFF-40A8-B544-A5F83AFDA984Q33851876-487AFA3A-05B8-4D2C-AE7D-6F2082FD82FEQ33955013-99CD8273-D76D-4F5D-A351-F49CB0348046Q33966083-300B6C58-8D3A-41DB-88A8-5E745D2073CAQ34186338-AA27664D-FED2-4C7C-A91B-DEFB7A23B49AQ34194655-3DC50B99-FF48-4789-9301-C16125677656Q34351552-507C40B5-CB41-4BC2-B603-54A3B32B04BDQ34391135-36EB8A85-3A9F-4C3B-9BBD-4EAD33412111Q34464452-45A49692-8D61-4157-BCBB-2067B4E9EE90Q34487230-1EA1DD18-F990-4C64-8905-B4D6B5C0218CQ34499248-B53FFF7F-88A4-4F32-B79B-841351E30B1CQ34563350-A42D1344-BFAB-422C-B05C-C1B8F924C6FAQ34604975-C550144A-313A-4BB7-A3CB-A1E9FCCB31C0Q34615653-1C76928E-1BEB-4042-B543-24CB738DAC2BQ34631337-5C775C24-310E-4589-9A39-F4C9E08501D3Q34661001-DA2FB5FD-38BD-43E5-A3CB-F18E70BD4AD5Q34992935-1480F996-9D7B-4083-9DEC-24F2C092F608Q35048768-DB662958-C414-426E-BD15-18592266675CQ35074664-29D48FC5-93FF-41BD-AE5E-D94BBFE577A4Q35106891-75930CC4-BDCD-4DD9-A5F6-DBC917CCB781Q35162784-10D30623-DA32-4B4A-8853-A366B27CDD76
P2860
Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.
@ast
Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.
@en
type
label
Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.
@ast
Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.
@en
prefLabel
Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.
@ast
Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.
@en
P2093
P1476
Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.
@en
P2093
Kathleen Egan
Keith D Lindor
Kelly Burak
Paul Angulo
Tousif M Pasha
P2860
P304
P356
10.1111/J.1572-0241.2004.04067.X
P407
P577
2004-03-01T00:00:00Z